Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling
- PMID: 16330319
- PMCID: PMC2647984
- DOI: 10.1016/j.cmet.2005.11.011
Osteoprotegerin, the bone protector, is a surprising target for beta-catenin signaling
Abstract
Osteoblasts influence bone mass by the amount of bone they synthesize and by regulating osteoclasts, the cells that degrade bone. In the December issue of Developmental Cell, Kieslinger et al. (2005) show that immature osteoblasts regulate expression of the osteoclast inhibitor, osteoprotegerin, through an early B cell factor and β-catenin signaling.
References
-
- Glass DA, 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, Taketo MM, Long F, McMahon AP, Lang RA, Karsenty G. Dev Cell. 2005;8:751–764. - PubMed
-
- Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. Dev Cell. 2005;8:727–738. - PubMed
-
- Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, Deng L, Clemens TL, Williams BO. J Biol Chem. 2005;280:21162–21168. - PubMed
-
- Huelsken J, Birchmeier W. Curr Opin Genet Dev. 2001;11:547–553. - PubMed
-
- Jackson A, Vayssiere B, Garcia T, Newell W, Baron R, Roman-Roman S, Rawadi G. Bone. 2005;36:585–598. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
